CAS 133804-44-1

5-METHYL-2-(1-PIPERAZINYL)BENZENESULFONIC ACID MONOHYDRATE

Description:

5-Methyl-2-(1-piperazinyl)benzenesulfonic acid monohydrate is a chemical compound characterized by its sulfonic acid functional group, which imparts strong acidic properties. The presence of a piperazine ring contributes to its potential as a pharmacological agent, often enhancing solubility and bioavailability. This compound typically appears as a white to off-white crystalline solid and is soluble in water due to the sulfonic acid group. Its molecular structure includes a methyl group and a piperazine moiety, which can influence its interaction with biological targets. The monohydrate form indicates the presence of one water molecule per molecule of the compound, which can affect its stability and solubility. This substance is often utilized in research and development, particularly in medicinal chemistry, where it may serve as a building block for synthesizing more complex pharmaceutical compounds. Safety data should be consulted for handling and storage, as with any chemical substance, to ensure proper laboratory practices.

Formula: C₁₁H₁₆N₂O₃S

InChI: InChI=1/C11H16N2O3S/c1-9-2-3-10(11(8-9)17(14,15)16)13-6-4-12-5-7-13/h2-3,8,12H,4-7H2,1H3,(H,14,15,16)

SMILES: Cc1ccc(c(c1)S(=O)(=O)O)N1CCNCC1

Synonyms:

• Caldaret [INN]
• 5-Methyl-2-(piperazin-1-yl)benzenesulfonic acid
• Caldaret
• Mcc 135
• Unii-9L3Y3Ij2Hi
• Benzenesulfonic acid, 5-methyl-2-(1-piperazinyl)-
• 5-METHYL-2-(1-PIPERAZINYL)BENZENESULFONIC ACID MONOHYDRATE

Bz 423

CAS: 133804-44-1

Bz 423

Purity: ≥98%

Molecular weight: 440.92g/mol

Ref: 54-BUP20716

Caldaret

CAS: 133804-44-1

Caldaret is an analog of the natural hormone calcitonin, which has a number of biological effects. Caldaret is used for the treatment of osteoporosis, but it can also be used to treat bowel disease. Caldaret works by inhibiting the activity of enzymes that break down or destroy cytosolic calcium (Ca2+). It has been shown to reduce symptoms of inflammatory bowel disease, such as abdominal pain and diarrhea, in animal models and humans. Caldaret may be administered as a low-dose group with degarelix acetate for prostate cancer therapy. This combination therapy may be effective in preventing the recurrence of cancer cells due to its ability to inhibit cardiac ryanodine receptor and Ca2+ overload in heart tissue.

Formula: C₁₁H₁₆N₂O₃S

Purity: Min. 95%

Molecular weight: 256.32 g/mol

Ref: 3D-IFA80444

Caldaret

CAS: 133804-44-1

Caldaret is an intracellular Ca2+ handling modulator that acts through reverse mode Na+/Ca2+ exchanger inhibition.

Formula: C₁₁H₁₆N₂O₃S

Color and Shape: Solid

Molecular weight: 256.32

Ref: TM-T14857